FR2677653B1 - - Google Patents

Info

Publication number
FR2677653B1
FR2677653B1 FR9107363A FR9107363A FR2677653B1 FR 2677653 B1 FR2677653 B1 FR 2677653B1 FR 9107363 A FR9107363 A FR 9107363A FR 9107363 A FR9107363 A FR 9107363A FR 2677653 B1 FR2677653 B1 FR 2677653B1
Authority
FR
France
Prior art keywords
pct
hepatitis
cytochrome
peptide
autoimmune hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9107363A
Other languages
English (en)
French (fr)
Other versions
FR2677653A1 (fr
Inventor
Fernando Alvarez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9107363A priority Critical patent/FR2677653A1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to ES92912543T priority patent/ES2133320T3/es
Priority to DE69229269T priority patent/DE69229269T2/de
Priority to CA002111672A priority patent/CA2111672A1/en
Priority to AT92912543T priority patent/ATE180512T1/de
Priority to PCT/FR1992/000539 priority patent/WO1992022656A1/fr
Priority to JP50076893A priority patent/JP3284240B2/ja
Priority to EP92912543A priority patent/EP0589993B1/fr
Priority to US08/162,149 priority patent/US5830667A/en
Publication of FR2677653A1 publication Critical patent/FR2677653A1/fr
Application granted granted Critical
Publication of FR2677653B1 publication Critical patent/FR2677653B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9107363A 1991-06-17 1991-06-17 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune. Granted FR2677653A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR9107363A FR2677653A1 (fr) 1991-06-17 1991-06-17 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune.
DE69229269T DE69229269T2 (de) 1991-06-17 1992-06-16 Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
CA002111672A CA2111672A1 (en) 1991-06-17 1992-06-16 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
AT92912543T ATE180512T1 (de) 1991-06-17 1992-06-16 Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
ES92912543T ES2133320T3 (es) 1991-06-17 1992-06-16 Fragmentos peptidicos procedentes del citocromo humano p450 iid6, anticuerpos antifragmentos peptidicos y sus aplicaciones en el diagnostico en la hepatitis autoinmune.
PCT/FR1992/000539 WO1992022656A1 (fr) 1991-06-17 1992-06-16 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune
JP50076893A JP3284240B2 (ja) 1991-06-17 1992-06-16 ヒトチトクロームｐ４５０ｉｉｄ６由来ペプチド断片、抗ペプチド断片抗体、及びそれらの自己免疫性肝炎の診断における応用
EP92912543A EP0589993B1 (fr) 1991-06-17 1992-06-16 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune
US08/162,149 US5830667A (en) 1991-06-17 1992-06-16 Human P450 IID6 cytochrome-derived peptide fragments, anti-peptide fragment antibodies, applications thereof in the diagnosis of autoimmune hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9107363A FR2677653A1 (fr) 1991-06-17 1991-06-17 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune.

Publications (2)

Publication Number Publication Date
FR2677653A1 FR2677653A1 (fr) 1992-12-18
FR2677653B1 true FR2677653B1 (enExample) 1995-04-14

Family

ID=9413909

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9107363A Granted FR2677653A1 (fr) 1991-06-17 1991-06-17 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune.

Country Status (9)

Country Link
US (1) US5830667A (enExample)
EP (1) EP0589993B1 (enExample)
JP (1) JP3284240B2 (enExample)
AT (1) ATE180512T1 (enExample)
CA (1) CA2111672A1 (enExample)
DE (1) DE69229269T2 (enExample)
ES (1) ES2133320T3 (enExample)
FR (1) FR2677653A1 (enExample)
WO (1) WO1992022656A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985542A (en) * 1996-05-20 1999-11-16 Sumitomo Chemical Company, Limited Diagnostic kit
DE19805815C1 (de) * 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
DE19930933B4 (de) * 1998-07-10 2005-05-25 Imtec Immundiagnostika Gmbh Verfahren zur Bestimmung von anti-LKM 1-Antikörpern
US6787303B1 (en) 1999-04-01 2004-09-07 Alton Ochsner Medical Foundation Identification of a novel retrovirus associated with primary sclerosing cholangitis and autoimmune hepatitis
CA2421680A1 (en) * 2000-09-29 2002-04-04 Merck & Co., Inc. Antibodies for human cytochrome p450 2d6
US20040096874A1 (en) * 2002-04-11 2004-05-20 Third Wave Technologies, Inc. Characterization of CYP 2D6 genotypes
EP2454276A4 (en) * 2008-07-17 2013-07-10 Inter K Pty Ltd THERAPEUTIC AGENTS
CN102955030A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体ana的试剂盒及其检测方法
CN102707055A (zh) * 2012-06-11 2012-10-03 郑州安图绿科生物工程有限公司 一种联合或单独检测自身免疫性肝病相关抗体的试剂盒及其检测方法
CN102955027A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体抗lc-1抗体的试剂盒及其检测方法
CN102955026A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体asma的试剂盒及其检测方法
CR20230131A (es) 2015-05-06 2023-06-23 Immatics Biotechnologies Gmbh NUEVOS PÉPTIDOS Y NUEVAS COMBINACIONES DE PÉPTIDOS Y DE SOPORTES PARA LA INMUNOTERAPIA CONTRA EL CARCINOMA COLORRECTAL Y OTROS TIPOS DE CÁNCER (Divisional Exp. 2017-0497)
GB201507719D0 (en) 2015-05-06 2015-06-17 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
EP3477303A1 (en) 2017-10-27 2019-05-01 Medizinische Hochschule Hannover Method and means for diagnosing autoimmune hepatitis using autoantibody markers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
JP3284240B2 (ja) 2002-05-20
EP0589993A1 (fr) 1994-04-06
JPH06510663A (ja) 1994-12-01
US5830667A (en) 1998-11-03
ATE180512T1 (de) 1999-06-15
ES2133320T3 (es) 1999-09-16
CA2111672A1 (en) 1992-12-23
DE69229269T2 (de) 1999-11-11
FR2677653A1 (fr) 1992-12-18
EP0589993B1 (fr) 1999-05-26
WO1992022656A1 (fr) 1992-12-23
DE69229269D1 (de) 1999-07-01

Similar Documents

Publication Publication Date Title
FR2677653B1 (enExample)
Capra et al. Light chain sequences of human IgM cold agglutinins
EP0608261A4 (en) COMPOSITION OF AN IMMUNREACTIVE HEPATITIS C VIRUS POLYPEPTIDE.
WO1995012677A3 (en) Immunodominant human t-cell epitopes of hepatitis c virus
DK0700445T3 (da) Stressproteiner og anvendelser deraf
GR3023860T3 (en) Monomeric and dimeric antibody-fragment fusion proteins.
CA2102208A1 (en) Binding domains in notch and delta proteins
DE69840334D1 (de) Puffern zur stabilizierung von hcv antigenen
ATE159727T1 (de) Kleinste erkennungseinheit eines pem-mucin- ''tandem repeat''-spezifischen monoklonalen antikoerpers
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
CA2093667A1 (en) Mouse monoclonal antibodies and uses thereof
EP2258725A3 (en) Cytokine receptor zcytor17
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
WO1999033989A3 (en) Rantes mutants and therapeutic applications thereof
DK0687300T3 (da) LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
EP1326895B8 (fr) Anticorps monoclonaux diriges contre des virus de l'hepatite b
EP0955366A4 (en) ANTIGENIC PROTEIN FROM MALASSEZIA
ES8800052A1 (es) Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale
CA2038577A1 (en) Utilization and delivery of enzymes
IL109761A0 (en) Oligopeptides derived from c-reactive protein fragments
ATE276277T1 (de) Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100226